According to Redhill Biopharma's latest financial reports the company has $3.47 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $-48.4 M | -645.35% |
2021-12-31 | $8.87 M | -35.99% |
2020-12-31 | $13.86 M | -76.89% |
2019-12-31 | $60 M | 17.22% |
2018-12-31 | $51.18 M | 13.58% |
2017-12-31 | $45.06 M | -28.13% |
2016-12-31 | $62.7 M | 4.37% |
2015-12-31 | $60.07 M | 140.2% |
2014-12-31 | $25.01 M | 109.74% |
2013-12-31 | $11.92 M | -37.3% |
2012-12-31 | $19.01 M | 1.23% |
2011-12-31 | $18.78 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Sanofi SNY | $82.20 B | 2,368,191.56% | ๐ซ๐ท France |
Merck MRK | $37.63 B | 1,084,169.66% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $16.28 B | 469,159.58% | ๐ฌ๐ง UK |
Teva Pharmaceutical Industries TEVA | $8.12 B | 234,011.21% | ๐ฎ๐ฑ Israel |
Taro Pharmaceutical TARO | $1.77 B | 51,155.83% | ๐ฎ๐ฑ Israel |